Showing results (31-40 of 145) with videos related to
Sort By:
Pageof 15
Multiple Sclerosis and Related Disorders|August 24, 2024
Comparative analysis of cognitive and physical characteristics in late-onset, adult-onset and early-onset multiple sclerosis patientsSerkan Ozakbas, Ergi Kaya, Taha Aslan, et al.Multiple Sclerosis and Related Disorders|January 5, 2023
Effect of exergaming in people with restless legs syndrome with multiple sclerosis: A single-blind randomized controlled trialAsiye Tuba Ozdogar, Ozge Ertekin, Turhan Kahraman, et al.Multiple Sclerosis and Related Disorders|December 13, 2021
Fatigue is associated with physical inactivity in people with multiple sclerosis despite different environmental backgrounds: Merging and comparing cohorts from Turkey and IsraelAsiye Tuba Ozdogar, Turhan Kahraman, Serkan Ozakbas, et al.Archives of Physical Medicine and Rehabilitation|November 3, 2024
Effect of Telerehabilitation-Based Motor Imagery Training on Pain and Related Factors in People With Multiple Sclerosis: Randomized Controlled Pilot TrialHilal Karakas, Turhan Kahraman, Asiye Tuba Ozdogar, et al.Multiple Sclerosis and Related Disorders|February 12, 2020
Effect of video-based exergaming on arm and cognitive function in persons with multiple sclerosis: A randomized controlled trialAsiye Tuba Ozdogar, Ozge Ertekin, Turhan Kahraman, et al.Journal of Clinical Neurology (Seoul, Korea)|October 18, 2014
Contingent negative variation is associated with cognitive dysfunction and secondary progressive disease course in multiple sclerosisUtku Uysal, Fethi Idiman, Egemen Idiman, et al.Multiple Sclerosis and Related Disorders|January 15, 2022
Comparison of SARS-CoV-2 antibody response after two doses of mRNA and inactivated vaccines in multiple sclerosis patients treated with disease-modifying therapiesSerkan Ozakbas, Cavid Baba, Yavuz Dogan, et al.Multiple Sclerosis and Related Disorders|April 15, 2026
Real-world transition from uncontrolled disease to stability: Three-year Pre-post natalizumab comparison in relapsing multiple sclerosisSerkan Ozakbas, Orkhan Mammadov, Said Alizada, et al.Acta Neurologica Scandinavica|January 19, 2022
Self-injectable DMTs in relapsing MS: NEDA assessment at 10 years in a real-world cohortSerkan Ozakbas, Bilge Piri Cinar, Cavid Baba, et al.Acta Neurologica Belgica|January 18, 2024
Predictors of relapse severity in multiple sclerosisCavid Baba, Zuhal Abasiyanik, Yasemin Simsek, et al.Pageof 15